NHS Greater Glasgow & Clyde Area Drug and Therapeutics Committee
Greater Glasgow and Clyde Medicines
Medicines Update

Yellow Card Reporting

The following is a message from Yellow Card Scotland:

‘’The Yellow Card (YC) reporting data for Scotland for the Year 2016-17 is now available in our Annual Report and our local Health Board report for NHS Greater Glasgow and Clyde (GG&C). There were 1463 Yellow Card Reports in Scotland and 288 of these came from GG&C. That’s a 1% increase on 2015-16 for Scotland but a 2% decrease for GG&C.

For several years, patient group reporting throughout Scotland has been increasing and made up 28% of all the reports in GG&C. Patient groups remain the highest reporting group, followed by hospital doctors (22%) and hospital pharmacists (15%).

The top reported medicines in GG&C were Meningococcal B Vaccines; HPV Vaccines; Rivaroxaban; Influenza Vaccines (Intranasal) and Rocuronium Bromide.

 Of the reports submitted by healthcare professionals, 67% were made from within hospitals in GG&C. Consistently with the rest of Scotland, GP reporting continues to decline in GG&C over the last four years; there was a further 8% decrease in Scotland since 2015/16. Nurse reporting (incorporating all community) has also declined by 22%. There have been increases in GP reporting throughout the rest of the UK where electronic YC reporting is embedded within clinical systems (such as SystmOne and Vision). We recognise this issue in YCC Scotland but do encourage you to report online, via the App (visit the App store or Google play), or on paper until this is available. Our Yellow Card App will soon be getting a revamp to make it much more user friendly.

Thank you to everyone who submitted a Yellow Card report. Every report plays a critical role in understanding the benefits and risks of medicines on the market and identifying important safety issues. Awareness of any new risks is vital to protect our patients from preventable harm. Please stay up to date on key medicines safety issues by subscribing to the MHRA Drug Safety Updates.‘’


Key messages for GGC staff:

  • All Healthcare professionals should continue to report adverse reactions via a Yellow Card. Don’t assume it’s someone else’s responsibility, duplicate reports are better than none
  • A procurement exercise is underway for new GP IT systems and there are plans to integrate Yellow Card reporting with these systems from April 2019
  • Refer to Yellow Card Centre Scotland for details on why, what, how and who can report


Published 24/01/18